PTPRC and neoplasm: To further dissect the cellular origins of increased PD-L1, we analysed PD-L1 expression on tumour and other non-immune cells (CD45−), MDSCs (CD45+CD11b+Gr1+) and macrophages (CD45+CD11b+F4/80+) in the TME by flow cytometry.